Legal Psychedelics Pathway to Revenue – Trade To Black 18



The interview with Payon is about Numinus latest Q4 earnings. Some of the highlights from the earnings were a 202% increase in client appointments, meaning people scheduling appointments at the ketamine clinics within the State of Utah. Over 17,000 client appointments were made in their Q4 earnings.

We also touch on how the Q4 earnings were their first earnings report since they acquired a psychedelic company in the space called Novamind back in June 2022. The main reason they acquired Novamind was for their clinical model and footprint in the state of Utah and Arizona.

We also touched on the roadmap for their pathway to profitability. Payton outlines that with their current research partnership with the mental research institutions MAPS located in California, MDMA will be legalized within 12 months. Numinus is the company leader in the space related to MDMA research and distribution. He outlined the market potential for North America for MDMA in the interview.

Also, I ask what they need to focus on most going into 2023 to continue to grow and eventually turn a profit.

Right now Numinus is generating lots of revenue but currently is not profitable, which is expected this early in the game.

More Numinus Wellness
Numinus Psychedelic 2023 Breakthrough Research –https://youtu.be/fdJy5sNrBR4
Numinus Completes Novamind Acquisition https://youtu.be/ICC6dCDXpFU

Timestamps
1:23 Big Takeaway For Latest Q4 Earnings Report
3:55 What is Numinus Pathway to Revenue
06:23 Colorado’s Legal Psychedelic progress
07:30 Psychedelic New Client Appointments
09:00 Arizona Current Health Care System
10:47 Revenue from Psychedelic Research
15:27 What separates Numinus Wellness from the rest?
18:00 MDMA is Legalized by Health Canada
19:34 Numinus Partnership with MDA
24:39 Canada Health Care System Failing

Add us on
Linkedin: https://www.linkedin.com/company/the-…
TikTok: https://www.tiktok.com/@thedalesreport
Instagram: https://www.instagram.com/thedalesrep…
Website: https://thedalesreport.com/

Written by: Shadd Dales
Edited by: Hanz Carlos
Art: Ayoub Allaoui

Special Thanks to Payton Nyquvest, CEO Numinus Wellness TSX: NUMI

For copyright matters please get in touch with us at: sdales@thedalesreport.com

The Dales Report Inc. disclosure policy applies to this video: https://thedalesreport.com/disclosure/

source